<SUBMISSION>
<SECRELEASE-DATETIME> 20220414-164204 ⇐ Metadata from SEC Info (ET)
<SECWEBSITE-DATETIME> 20220414-164115 ⇐ Metadata from SEC Info (ET)
<ACCEPTANCE-DATETIME> 20220414-164023 ⇐ Filing accepted by SEC (ET)
<ACCESSION-NUMBER> 0001737287-22-000023
<TYPE> SC TO-C
<PUBLIC-DOCUMENT-COUNT> 2
<FILING-DATE> 20220414
<DATE-OF-FILING-DATE-CHANGE> 20220414
|
<SUBJECT-COMPANY>
<COMPANY-DATA>
<CONFORMED-NAME> Allogene Therapeutics, Inc.
<CIK> 0001737287
<ASSIGNED-SIC> 2836
<IRS-NUMBER> 823562771 ⇒ 82-3562771
<FISCAL-YEAR-END> 1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE> SC TO-C
<ACT> 34
<FILE-NUMBER> 005-90685
<FILM-NUMBER> 22827784
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1> 210 EAST GRAND AVENUE
<CITY> SOUTH SAN FRANCISCO
<STATE> CA
<ZIP> 94080
<PHONE> (650) 457-2700
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1> 210 EAST GRAND AVENUE
<CITY> SOUTH SAN FRANCISCO
<STATE> CA
<ZIP> 94080
</MAIL-ADDRESS>
</SUBJECT-COMPANY>
|
<FILED-BY>
<COMPANY-DATA>
<CONFORMED-NAME> Allogene Therapeutics, Inc.
<CIK> 0001737287
<ASSIGNED-SIC> 2836
<IRS-NUMBER> 823562771 ⇒ 82-3562771
<FISCAL-YEAR-END> 1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE> SC TO-C
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1> 210 EAST GRAND AVENUE
<CITY> SOUTH SAN FRANCISCO
<STATE> CA
<ZIP> 94080
<PHONE> (650) 457-2700
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1> 210 EAST GRAND AVENUE
<CITY> SOUTH SAN FRANCISCO
<STATE> CA
<ZIP> 94080
</MAIL-ADDRESS>
</FILED-BY>
|
<DOCUMENT>
<TYPE> SC TO-C
<SEQUENCE> 1
<FILENAME> allo-20220414xsctoxc.htm
<DESCRIPTION> SC TO-C
<TEXT>
Show <TEXT>: 4 lines (widest: 24,484 characters) - 25K bytes
</TEXT>
</DOCUMENT>
|
<DOCUMENT>
<TYPE> EX-99.2
<SEQUENCE> 2
<FILENAME> allo-20220414xsctoxcxexx992.htm
<DESCRIPTION> EX-99.2
<TEXT>
Show <TEXT>: 4 lines (widest: 7,363 characters) - 8K bytes
</TEXT>
</DOCUMENT>
|
</SUBMISSION> |
| ↑Top |
